NCT06477276View on ClinicalTrials.gov

Amygdala TIS for Depression

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

July 24, 2024

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2025

Conditions
Major Depressive Disorder
Interventions
DEVICE

Nervio-X

An 8-channel TIS device developed by NEURODOME Corporation.

Trial Locations (3)

200025

Ruijin Hospital, Shanghai

Unknown

Shanghai East Hospital, Shanghai

Tianjin Anding Hospital (Mental Health Center of Tianjin Medical University), Tianjin

All Listed Sponsors
collaborator

Tianjin Anding Hospital

OTHER

collaborator

Shanghai East Hospital

OTHER

lead

Ruijin Hospital

OTHER